Protocol for risk stratification of ischemic events and optimized individualized treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 13, 2011
Grant Date -
May 19, 2011
app pub date -
Jan 21, 2011
filing date -
Feb 22, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit preparation of an individualized assessment of ischemic event risk and individualized treatment of a subject.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully